Loading…

Experience and learning curve with transapical aortic valve implantation

Transapical transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients with degenerative aortic valve stenosis. The aim of this study was to assess a potential learning curve with the former technique based on the own experien...

Full description

Saved in:
Bibliographic Details
Published in:Herz 2009-08, Vol.34 (5), p.388-397
Main Authors: Wendt, Daniel, Eggebrecht, Holger, Kahlert, Philipp, Heine, Torsten, Kottenberg, Eva, Massoudy, Parwis, Kamler, Markus, Peters, Jürgen, Erbel, Raimund, Jakob, Heinz, Thielmann, Matthias
Format: Article
Language:ger
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 397
container_issue 5
container_start_page 388
container_title Herz
container_volume 34
creator Wendt, Daniel
Eggebrecht, Holger
Kahlert, Philipp
Heine, Torsten
Kottenberg, Eva
Massoudy, Parwis
Kamler, Markus
Peters, Jürgen
Erbel, Raimund
Jakob, Heinz
Thielmann, Matthias
description Transapical transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients with degenerative aortic valve stenosis. The aim of this study was to assess a potential learning curve with the former technique based on the own experience with this novel procedure. 40 consecutive high-risk patients (82 +/- 5 years, logistic EuroSCORE 42% +/- 16%) with symptomatic aortic valve stenosis underwent transapical aortic valve implantation (balloon expandable Sapien bioprosthesis, Edwards Lifesciences, Irvine, CA, USA) in the hybrid operating room between October 2007 and May 2009 at the West German Heart Center Essen. To assess a potential learning curve, patients were allocated and compared according to the implantation date (initial n = 20: 10/2007 to 10/2008; second n = 20: 11/2008 to 05/2009). All but one transapical aortic valve implantations were successful (procedural success rate 97.5%) and no prosthesis migration/embolization or coronary artery obstruction was observed. Comparing the groups, procedural time, fluoroscopy time, and contrast media volume decreased significantly (139 +/- 30 min vs. 112 +/- 41 min; 6.8 +/- 1.9 min vs. 5.5 +/- 1.5 min; 226 +/- 75 ml vs. 169 +/- 23 ml; p
doi_str_mv 10.1007/s00059-009-3265-y
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67614964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67614964</sourcerecordid><originalsourceid>FETCH-LOGICAL-p170t-8398edbffa7b647d2b8363be69d7393bb9dffbd27eb3aae64c0bed928c7b50f63</originalsourceid><addsrcrecordid>eNqFkD1PwzAURS0EoqXwA1hQJjbDs53Y8YiqliJVYoE5suMXMMoXtlPov6cSZWa6wz06urqEXDO4YwDqPgJAoSmApoLLgu5PyJxJVlApNT8lcxA5UK2FmpGLGD8AWKE5nJMZ04oxEMWcbFbfIwaPfY2Z6V3Wogm979-yego7zL58es9SMH00o69Nm5khJF9nO9MeWt-NremTSX7oL8lZY9qIV8dckNf16mW5odvnx6flw5aOTEGipdAlOts0RlmZK8dtKaSwKLVTQgtrtWsa67hCK4xBmddg0Wle1soW0EixILe_3jEMnxPGVHU-1tgehuAwxUoqyXIt839BzkBK4OIA3hzByXboqjH4zoR99XeS-AHfHmsu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21066023</pqid></control><display><type>article</type><title>Experience and learning curve with transapical aortic valve implantation</title><source>Springer Nature</source><creator>Wendt, Daniel ; Eggebrecht, Holger ; Kahlert, Philipp ; Heine, Torsten ; Kottenberg, Eva ; Massoudy, Parwis ; Kamler, Markus ; Peters, Jürgen ; Erbel, Raimund ; Jakob, Heinz ; Thielmann, Matthias</creator><creatorcontrib>Wendt, Daniel ; Eggebrecht, Holger ; Kahlert, Philipp ; Heine, Torsten ; Kottenberg, Eva ; Massoudy, Parwis ; Kamler, Markus ; Peters, Jürgen ; Erbel, Raimund ; Jakob, Heinz ; Thielmann, Matthias</creatorcontrib><description>Transapical transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients with degenerative aortic valve stenosis. The aim of this study was to assess a potential learning curve with the former technique based on the own experience with this novel procedure. 40 consecutive high-risk patients (82 +/- 5 years, logistic EuroSCORE 42% +/- 16%) with symptomatic aortic valve stenosis underwent transapical aortic valve implantation (balloon expandable Sapien bioprosthesis, Edwards Lifesciences, Irvine, CA, USA) in the hybrid operating room between October 2007 and May 2009 at the West German Heart Center Essen. To assess a potential learning curve, patients were allocated and compared according to the implantation date (initial n = 20: 10/2007 to 10/2008; second n = 20: 11/2008 to 05/2009). All but one transapical aortic valve implantations were successful (procedural success rate 97.5%) and no prosthesis migration/embolization or coronary artery obstruction was observed. Comparing the groups, procedural time, fluoroscopy time, and contrast media volume decreased significantly (139 +/- 30 min vs. 112 +/- 41 min; 6.8 +/- 1.9 min vs. 5.5 +/- 1.5 min; 226 +/- 75 ml vs. 169 +/- 23 ml; p &lt;or= 0,05). Predicted 30-day mortality for patients operated upon within the 1st period was 51% +/- 14% (logistic EuroSCORE) and 20% +/- 11% (STS Score [Society of Thoracic Surgeons]) compared to 32% +/- 12% and 13% +/- 7% in the 2nd period, while observed 30-day mortality decreased from 25% to 10%. This study reflects the authors' experience with transapical aortic valve implantation in patients presenting with a high surgical risk for conventional aortic valve replacement. Within this patient cohort improved clinical outcome, and lower morbidity and mortality demonstrate a learning curve. Improved results were achieved by (1) patient selection with regard to specific procedure-related risk factors, (2) careful preoperative patient preparation, (3) an optimum interventional and surgical approach, and (4) continuous application of this new procedure.</description><identifier>ISSN: 0340-9937</identifier><identifier>EISSN: 1615-6692</identifier><identifier>DOI: 10.1007/s00059-009-3265-y</identifier><identifier>PMID: 19711035</identifier><language>ger</language><publisher>Germany</publisher><subject>Aged, 80 and over ; Aortic Valve Stenosis - mortality ; Aortic Valve Stenosis - surgery ; Cardiac Catheterization - mortality ; Clinical Competence - statistics &amp; numerical data ; Female ; Germany - epidemiology ; Heart Valve Prosthesis - utilization ; Heart Valve Prosthesis Implantation - mortality ; Humans ; Male ; Patient Care Team ; Practice Patterns, Physicians' - statistics &amp; numerical data ; Prevalence ; Survival Analysis ; Survival Rate</subject><ispartof>Herz, 2009-08, Vol.34 (5), p.388-397</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19711035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wendt, Daniel</creatorcontrib><creatorcontrib>Eggebrecht, Holger</creatorcontrib><creatorcontrib>Kahlert, Philipp</creatorcontrib><creatorcontrib>Heine, Torsten</creatorcontrib><creatorcontrib>Kottenberg, Eva</creatorcontrib><creatorcontrib>Massoudy, Parwis</creatorcontrib><creatorcontrib>Kamler, Markus</creatorcontrib><creatorcontrib>Peters, Jürgen</creatorcontrib><creatorcontrib>Erbel, Raimund</creatorcontrib><creatorcontrib>Jakob, Heinz</creatorcontrib><creatorcontrib>Thielmann, Matthias</creatorcontrib><title>Experience and learning curve with transapical aortic valve implantation</title><title>Herz</title><addtitle>Herz</addtitle><description>Transapical transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients with degenerative aortic valve stenosis. The aim of this study was to assess a potential learning curve with the former technique based on the own experience with this novel procedure. 40 consecutive high-risk patients (82 +/- 5 years, logistic EuroSCORE 42% +/- 16%) with symptomatic aortic valve stenosis underwent transapical aortic valve implantation (balloon expandable Sapien bioprosthesis, Edwards Lifesciences, Irvine, CA, USA) in the hybrid operating room between October 2007 and May 2009 at the West German Heart Center Essen. To assess a potential learning curve, patients were allocated and compared according to the implantation date (initial n = 20: 10/2007 to 10/2008; second n = 20: 11/2008 to 05/2009). All but one transapical aortic valve implantations were successful (procedural success rate 97.5%) and no prosthesis migration/embolization or coronary artery obstruction was observed. Comparing the groups, procedural time, fluoroscopy time, and contrast media volume decreased significantly (139 +/- 30 min vs. 112 +/- 41 min; 6.8 +/- 1.9 min vs. 5.5 +/- 1.5 min; 226 +/- 75 ml vs. 169 +/- 23 ml; p &lt;or= 0,05). Predicted 30-day mortality for patients operated upon within the 1st period was 51% +/- 14% (logistic EuroSCORE) and 20% +/- 11% (STS Score [Society of Thoracic Surgeons]) compared to 32% +/- 12% and 13% +/- 7% in the 2nd period, while observed 30-day mortality decreased from 25% to 10%. This study reflects the authors' experience with transapical aortic valve implantation in patients presenting with a high surgical risk for conventional aortic valve replacement. Within this patient cohort improved clinical outcome, and lower morbidity and mortality demonstrate a learning curve. Improved results were achieved by (1) patient selection with regard to specific procedure-related risk factors, (2) careful preoperative patient preparation, (3) an optimum interventional and surgical approach, and (4) continuous application of this new procedure.</description><subject>Aged, 80 and over</subject><subject>Aortic Valve Stenosis - mortality</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Cardiac Catheterization - mortality</subject><subject>Clinical Competence - statistics &amp; numerical data</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Heart Valve Prosthesis - utilization</subject><subject>Heart Valve Prosthesis Implantation - mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Patient Care Team</subject><subject>Practice Patterns, Physicians' - statistics &amp; numerical data</subject><subject>Prevalence</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><issn>0340-9937</issn><issn>1615-6692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAURS0EoqXwA1hQJjbDs53Y8YiqliJVYoE5suMXMMoXtlPov6cSZWa6wz06urqEXDO4YwDqPgJAoSmApoLLgu5PyJxJVlApNT8lcxA5UK2FmpGLGD8AWKE5nJMZ04oxEMWcbFbfIwaPfY2Z6V3Wogm979-yego7zL58es9SMH00o69Nm5khJF9nO9MeWt-NremTSX7oL8lZY9qIV8dckNf16mW5odvnx6flw5aOTEGipdAlOts0RlmZK8dtKaSwKLVTQgtrtWsa67hCK4xBmddg0Wle1soW0EixILe_3jEMnxPGVHU-1tgehuAwxUoqyXIt839BzkBK4OIA3hzByXboqjH4zoR99XeS-AHfHmsu</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Wendt, Daniel</creator><creator>Eggebrecht, Holger</creator><creator>Kahlert, Philipp</creator><creator>Heine, Torsten</creator><creator>Kottenberg, Eva</creator><creator>Massoudy, Parwis</creator><creator>Kamler, Markus</creator><creator>Peters, Jürgen</creator><creator>Erbel, Raimund</creator><creator>Jakob, Heinz</creator><creator>Thielmann, Matthias</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200908</creationdate><title>Experience and learning curve with transapical aortic valve implantation</title><author>Wendt, Daniel ; Eggebrecht, Holger ; Kahlert, Philipp ; Heine, Torsten ; Kottenberg, Eva ; Massoudy, Parwis ; Kamler, Markus ; Peters, Jürgen ; Erbel, Raimund ; Jakob, Heinz ; Thielmann, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p170t-8398edbffa7b647d2b8363be69d7393bb9dffbd27eb3aae64c0bed928c7b50f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2009</creationdate><topic>Aged, 80 and over</topic><topic>Aortic Valve Stenosis - mortality</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Cardiac Catheterization - mortality</topic><topic>Clinical Competence - statistics &amp; numerical data</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Heart Valve Prosthesis - utilization</topic><topic>Heart Valve Prosthesis Implantation - mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Patient Care Team</topic><topic>Practice Patterns, Physicians' - statistics &amp; numerical data</topic><topic>Prevalence</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wendt, Daniel</creatorcontrib><creatorcontrib>Eggebrecht, Holger</creatorcontrib><creatorcontrib>Kahlert, Philipp</creatorcontrib><creatorcontrib>Heine, Torsten</creatorcontrib><creatorcontrib>Kottenberg, Eva</creatorcontrib><creatorcontrib>Massoudy, Parwis</creatorcontrib><creatorcontrib>Kamler, Markus</creatorcontrib><creatorcontrib>Peters, Jürgen</creatorcontrib><creatorcontrib>Erbel, Raimund</creatorcontrib><creatorcontrib>Jakob, Heinz</creatorcontrib><creatorcontrib>Thielmann, Matthias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Herz</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wendt, Daniel</au><au>Eggebrecht, Holger</au><au>Kahlert, Philipp</au><au>Heine, Torsten</au><au>Kottenberg, Eva</au><au>Massoudy, Parwis</au><au>Kamler, Markus</au><au>Peters, Jürgen</au><au>Erbel, Raimund</au><au>Jakob, Heinz</au><au>Thielmann, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience and learning curve with transapical aortic valve implantation</atitle><jtitle>Herz</jtitle><addtitle>Herz</addtitle><date>2009-08</date><risdate>2009</risdate><volume>34</volume><issue>5</issue><spage>388</spage><epage>397</epage><pages>388-397</pages><issn>0340-9937</issn><eissn>1615-6692</eissn><abstract>Transapical transcatheter aortic valve implantation has emerged as an alternative to conventional aortic valve replacement in high-risk patients with degenerative aortic valve stenosis. The aim of this study was to assess a potential learning curve with the former technique based on the own experience with this novel procedure. 40 consecutive high-risk patients (82 +/- 5 years, logistic EuroSCORE 42% +/- 16%) with symptomatic aortic valve stenosis underwent transapical aortic valve implantation (balloon expandable Sapien bioprosthesis, Edwards Lifesciences, Irvine, CA, USA) in the hybrid operating room between October 2007 and May 2009 at the West German Heart Center Essen. To assess a potential learning curve, patients were allocated and compared according to the implantation date (initial n = 20: 10/2007 to 10/2008; second n = 20: 11/2008 to 05/2009). All but one transapical aortic valve implantations were successful (procedural success rate 97.5%) and no prosthesis migration/embolization or coronary artery obstruction was observed. Comparing the groups, procedural time, fluoroscopy time, and contrast media volume decreased significantly (139 +/- 30 min vs. 112 +/- 41 min; 6.8 +/- 1.9 min vs. 5.5 +/- 1.5 min; 226 +/- 75 ml vs. 169 +/- 23 ml; p &lt;or= 0,05). Predicted 30-day mortality for patients operated upon within the 1st period was 51% +/- 14% (logistic EuroSCORE) and 20% +/- 11% (STS Score [Society of Thoracic Surgeons]) compared to 32% +/- 12% and 13% +/- 7% in the 2nd period, while observed 30-day mortality decreased from 25% to 10%. This study reflects the authors' experience with transapical aortic valve implantation in patients presenting with a high surgical risk for conventional aortic valve replacement. Within this patient cohort improved clinical outcome, and lower morbidity and mortality demonstrate a learning curve. Improved results were achieved by (1) patient selection with regard to specific procedure-related risk factors, (2) careful preoperative patient preparation, (3) an optimum interventional and surgical approach, and (4) continuous application of this new procedure.</abstract><cop>Germany</cop><pmid>19711035</pmid><doi>10.1007/s00059-009-3265-y</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-9937
ispartof Herz, 2009-08, Vol.34 (5), p.388-397
issn 0340-9937
1615-6692
language ger
recordid cdi_proquest_miscellaneous_67614964
source Springer Nature
subjects Aged, 80 and over
Aortic Valve Stenosis - mortality
Aortic Valve Stenosis - surgery
Cardiac Catheterization - mortality
Clinical Competence - statistics & numerical data
Female
Germany - epidemiology
Heart Valve Prosthesis - utilization
Heart Valve Prosthesis Implantation - mortality
Humans
Male
Patient Care Team
Practice Patterns, Physicians' - statistics & numerical data
Prevalence
Survival Analysis
Survival Rate
title Experience and learning curve with transapical aortic valve implantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A37%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20and%20learning%20curve%20with%20transapical%20aortic%20valve%20implantation&rft.jtitle=Herz&rft.au=Wendt,%20Daniel&rft.date=2009-08&rft.volume=34&rft.issue=5&rft.spage=388&rft.epage=397&rft.pages=388-397&rft.issn=0340-9937&rft.eissn=1615-6692&rft_id=info:doi/10.1007/s00059-009-3265-y&rft_dat=%3Cproquest_pubme%3E67614964%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p170t-8398edbffa7b647d2b8363be69d7393bb9dffbd27eb3aae64c0bed928c7b50f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21066023&rft_id=info:pmid/19711035&rfr_iscdi=true